E. Antonio Chiocca, MD
Affiliations: | 2004-2012 | Neurosurgery | Ohio State University, Columbus, Columbus, OH |
| 2012- | Neurosurgery | Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States |
Google:
"E. Chiocca"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Balveen Kaur | collaborator | ||
| Stephen B Tatter | collaborator | 1990- | Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Noh MH, Kang JM, Miller AA, et al. (2024) Targeting IGF2-IGF1R Signaling to Reprogram the Tumor Microenvironment for Enhanced Viro-Immunotherapy. Neuro-Oncology |
| Vazaios K, Stavrakaki Ε, Vogelezang LB, et al. (2024) The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles. Molecular Therapy. Oncology. 32: 200804 |
| Reddy R, Yan SC, Hasanpour Segherlou Z, et al. (2023) Oncolytic viral therapy: a review and promising future directions. Journal of Neurosurgery. 1-9 |
| Koch MS, Zdioruk M, Nowicki MO, et al. (2023) Uncovering transcriptomic landscape alterations of CAN-2409 in and glioma models. Frontiers in Medicine. 10: 1140352 |
| Ma R, Li Z, Chiocca EA, et al. (2022) The emerging field of oncolytic virus-based cancer immunotherapy. Trends in Cancer |
| Tian L, Xu B, Chen Y, et al. (2022) Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity. Nature Cancer |
| Berger G, Knelson EH, Jimenez-Macias JL, et al. (2022) STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models. Proceedings of the National Academy of Sciences of the United States of America. 119: e2111003119 |
| Jenner AL, Smalley M, Goldman D, et al. (2022) Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy. Iscience. 25: 104395 |
| Bhere D, Choi SH, van de Donk P, et al. (2022) Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature Communications. 13: 2810 |
| Blitz SE, Kappel AD, Gessler FA, et al. (2022) Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword. International Journal of Molecular Sciences. 23 |